Omega Healthcare Investors, Inc. (NYSE:OHI) Given Consensus Rating of “Moderate Buy” by Analysts

Omega Healthcare Investors, Inc. (NYSE:OHI) has been given a consensus recommendation of “Moderate Buy” by the twelve research firms that are currently covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $40.18.

Several brokerages have issued reports on OHI. BNP Paribas raised shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 target price for the company in a report on Thursday, October 31st. BMO Capital Markets upgraded shares of Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 price objective for the company in a report on Monday, December 9th. Wells Fargo & Company reiterated an “overweight” rating and set a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Mizuho boosted their price target on Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a “neutral” rating in a research note on Thursday, December 5th. Finally, Royal Bank of Canada upped their price target on Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a report on Monday, November 11th.

Institutional Investors Weigh In On Omega Healthcare Investors

Hedge funds and other institutional investors have recently made changes to their positions in the business. UMB Bank n.a. grew its position in Omega Healthcare Investors by 353.4% during the third quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 516 shares during the period. Dunhill Financial LLC bought a new position in Omega Healthcare Investors in the 3rd quarter worth $31,000. True Wealth Design LLC bought a new stake in Omega Healthcare Investors during the third quarter valued at about $31,000. DiNuzzo Private Wealth Inc. bought a new stake in Omega Healthcare Investors during the third quarter valued at about $33,000. Finally, V Square Quantitative Management LLC increased its position in Omega Healthcare Investors by 49.5% in the third quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock worth $40,000 after buying an additional 323 shares in the last quarter. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Price Performance

OHI opened at $38.33 on Friday. Omega Healthcare Investors has a 1 year low of $27.53 and a 1 year high of $44.42. The stock has a 50-day moving average price of $39.62 and a 200-day moving average price of $38.50. The firm has a market cap of $10.35 billion, a PE ratio of 28.18, a P/E/G ratio of 1.22 and a beta of 0.99. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48.

Omega Healthcare Investors Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were given a $0.67 dividend. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 annualized dividend and a yield of 6.99%. Omega Healthcare Investors’s payout ratio is 197.06%.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.